Literature DB >> 16770259

Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study.

Seung-Young Yu1, Francisco Max Damico, Francesco Viola, Donald J D'Amico, Lucy H Young.   

Abstract

PURPOSE: To evaluate the morphologic effects of intravitreal triamcinolone acetonide (TA) on rabbit retina.
METHODS: Intravitreal injections of 0.5 mg, 1 mg, 4 mg, 8 mg, and 20 mg of TA (Kenalog-40; Bristol-Myers Squibb, Princeton, NJ) in 0.1 mL were given to pigmented rabbits. For control, 0.1 mL of TA vehicle and saline were injected. Animals were killed on day 14, and retinas were analyzed by light as well as electron microscopy.
RESULTS: No ophthalmoscopic change was found. Eyes injected with 0.5 mg and 1 mg of TA did not have morphologic abnormality. Eyes injected with 4 mg, 8 mg, and 20 mg showed destruction of photoreceptor outer segments and migration of macrophage-like cells in the subretinal space. Eyes injected with 20 mg showed more extensive damage and increased pigment granules in the retinal pigment epithelium cells with large oil droplets in the cytoplasm. Electron microscopy also showed loss of photoreceptor/retinal pigment epithelium interdigitations. Eyes injected with vehicle or saline did not show morphologic changes.
CONCLUSION: Single intravitreal injection of 0.5 mg or 1 mg of TA did not produce morphologic retinal changes in pigmented rabbits. However, injections of 4 mg, 8 mg, and 20 mg of TA produced outer retina toxic effects. These findings suggest that long-term retinal toxicity studies should be carried out, using single and repeated injections before this therapy becomes more widely used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770259     DOI: 10.1097/00006982-200605000-00006

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  21 in total

1.  Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.

Authors:  Marina V Tikhonovich; Aleksei K Erdiakov; Svetlana A Gavrilova
Journal:  Int Ophthalmol       Date:  2017-06-21       Impact factor: 2.031

2.  Acute retinal necrosis after intraocular triamcinolone acetonide injection.

Authors:  Susie Chang; David J Weissgold; Jack A Singer; Lucia Sobrin
Journal:  Retin Cases Brief Rep       Date:  2010

3.  Intravitreal triamcinolone acetonide: a "real world" analysis of visual acuity, pressure and outcomes.

Authors:  Victor Manuel Villegas; Aaron Samuel Gold; Andrea Wildner; Azeema Latiff; Timothy Garrett Murray
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  Safety of intravitreal triamcinolone acetonide: an electrophysiologic and histopathological study in rabbits.

Authors:  Laila Hassan M El-Shazly; Amal Ahmad El-Gohary; Ghada Ghanem El-Hossary
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

5.  Evaluation of potential retinal toxicity of adalimumab (Humira).

Authors:  Miltiadis Tsilimbaris; Vasilios F Diakonis; Irini Naoumidi; Spyridon Charisis; Iraklis Kritikos; George Chatzithanasis; Thekla Papadaki; Sotiris Plainis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-19       Impact factor: 3.117

6.  Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells.

Authors:  Yoko Miura; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-03       Impact factor: 3.117

7.  [Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling].

Authors:  G B Jaissle; K U Bartz-Schmidt; P Szurman
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

8.  Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study.

Authors:  Maurício Maia; Fernando Marcondes Penha; Michel Eid Farah; Eduardo Dib; André Príncipe; Acácio A S Lima Filho; Octaviano Magalhães; Edna Freymüller; Eduardo B Rodrigues
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-11       Impact factor: 3.117

9.  Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.

Authors:  Claudia Schulze-Döbold; Michel Weber
Journal:  Int Ophthalmol       Date:  2008-07-10       Impact factor: 2.031

10.  Histopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.

Authors:  S J Kang; I Schmack; H E Benson; H E Grossniklaus
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.